Within the last fifteen years barbital and phenobarbital have achieved a justifiable popularity as sedatives and anticonvulsants. In spite of widespread use, reports of untoward reactions are not numerous, and there seems to be a general tendency to regard these drugs as harmless. A careful survey of the literature shows that this idea is not entirely correct, and the present purpose is to call attention to certain reactions which may occur following the use of barbital and phenobarbital.
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Menninger5 gives a very complete review of the 43 cases reported before I928, and emphasing the skin eruptions, adds three from his own clinic.
It is impossible to state the frequency with which reactions occur. Prior to I920, when larger doses were in vogue, reactions appear to have been rather common. With the use of smaller doses reactions have been less frequent, but have by no means disappeared. Menninger estimates reactions as occurring in one to three per cent of the cases. It is significant that most manufacturers of the drugs advise small doses and their advertising circulars warn of all the possible reactions. Little attention has been paid to this advice, and on the contrary when reactions do occur the tendency is to call them everything except drug reactions.
There are two distinct types of reaction,-a general systemic reaction with signs of acute poisoning, and skin reactions, with or without mild systemic disturbance. Menninger further classifies the skin reactions into the urticarial type, and the toxic type characterized by a diffuse erythematous maculo-papular rash. Occasionally vesicles have been noted with the dermatitis and in the cases reported by Heuber3 and Haxthausen2 hemorrhagic areas developed. The duration of the skin rash has varied greatly, ranging from two days to three weeks. Exfoliative dermatitis and pigmentation of the skin have been reported.
Although most of the severe reactions have occurred after large doses, Phillips6, Bothe', Jackson4, and Menninger5, all report re-actions in patients receiving i >2 grains per day. The amount required to produce reactions and the time of their appearance has varied greatly. Reactions have occurred within 24 hours of the institution of treatment and as late as 8 i days. Obviously this wide variation may lead to difficulty in diagnosis. In some cases it has been possible to resume medication with smaller doses, but in others, reactions have recurred every time treatment was resumed.
General systemic reactions have been observed but the literature contains very few references to this phase of the reaction. Stupor, mental disturbances, speech disorders and paresthesias have been reported in the true poisoning cases. Febrile reactions were common in this group.
It is interesting that the cases showing a severe general reaction had no dermatitis, while the dermatitis group showed a slight or moderate general reaction, such as fever, sometimes as high as I04-I05, nausea, vomiting, diarrhea, headache, stomatitis, pharyngitis, and conjunctivitis. Leucocytosis and eosinophilia were often striking findings.
The following eleven cases from the New Haven Hospital are reported; all occurred within the last five years. As far as we can ascertain the fatal case included in this series is the only one on record in which an autopsy was performed. These cases may be divided into two groups, those showing a skin reaction following therapeutic dosage (4 cases), and those showing a general reaction (7 cases) either from therapeutic dosage or from a larger amount taken with suicidal intent.
CASE REPORTS Case i. The patient was a white boy of 8½Y2 years suffering from chorea and rheumatic heart disease. He was given Luminal gr. Y4 q.i.d. Two days later the temperature began to vary from 97.4 to I00.4 . Nine days after the beginning of Luminal therapy a profuse pink, macular, skin rash was noted over the trunk and extensor surfaces of the extremities. Over the thighs and knees the rash was purple and urticarial in type, but was not influenced by adrenalin. Luminal was suspected as the cause and medication was stopped. Three days later the skin rash had disappeared and the temperature was normal. Because of the uncertainty concerning the role of Luminal, the drug was again given, gr. Y4 q.i.d.
for four doses. The following day the rash was again present and the temperature was elevated. Three days later all signs and symptoms had disappeared.
Case 2. The patient was a woman of 4I years presenting the signs and symptoms of chronic nephritis. Because of insomnia she was given i>2 gr. of Luminal on alternate days for a total of three doses. Nine days after the first dose and four days after the last dose, a profuse maculopapular rash was noted over the trunk and extremities. The rash was confluent for the most part and itching was pronounced. There was hyperemia of the conjunctivx and buccal mucosa, with two small red papules on the soft palate. During the next few days the temperature rose to I O3.4°. Leucocytosis varied between 22,000 and 25,000 with one to two per cent eosinophilia. The rash gradually became definitely urticarial. The erythema changed to a copper color, and the papules on the soft palate became ulcerated. Desquamation of the skin developed. One week after the rash appeared the patient went into coma, and pulmonary edema was noted. Death occurred two days later.
Autopsy: In addition to the findings of nephritis, several points were of interest. There was desquamation of the skin. The bronchi were congested and the mucosal surface appeared granular. Microscopic sections showed desquamation of the mucosa, edema, infiltration with leucocytes, and capillary engorgement. The alveoli were filled with fluid. The kidney pelves and ureters showed a process similar to that in the bronchi, and the lymph glands showed endothelial hyperplasia. After four days the edema of the skin had disappeared, the rash was purple in color and less intense, and pigmentation was evident. Ten days later all symptoms had disappeared and the blood count had returned to normal, but the brownish pigmentation of the skin persisted. Because of the possibility of Fowler's solution as a cause of the dermatitis, an intradermal skin test was made with a solution of Luminal.
A two per cent solution of sodium luminal (hypodermic tablet) was used for the skin test. Approximately 0.02 cc. was injected intradermally on the flexor surface of the forearm, and a similar amount of physiological salt solution was injected in the other arm as a control. Two minutes after injection an urticarial wheal with pseudopod formation developed at the point of the injection of Luminal. This increased rapidly in size and edema developed. After thirty minutes the area of edema measured 5 by 8 cm. The edema remained unchanged for two hours more and then gradually disappeared. The control test was negative.
Case 4. The patient was a white woman of 45 years who began taking Luminal gr. Y4 q.i.d. for the relief of pain caused by cystitis. One week later she noticed tingling and numbness of the third and fourth fingers of each hand. This was followed by the sensations of pain and burning of the skin of both hands. Luminal was continued at this dosage for five months and the symptoms persisted. The dose was then increased to six grains per day. After six weeks on this dosage a skin rash developed and eleven days later she was admitted to the hospital. At that time there was a diffuse maculopapular eruption over the entire body, most marked over the hands and inner aspect of the thighs. The W. B. C. was 5,500, with polymorphonuclears 6o per cent and eosinophiles 4 per cent. The drug was immediately discontinued and improvement began promptly. One week later all signs and symptoms had disappeared.
Case S. Ihe patient was a white male of 27 years who was given Luminal for the relief of pain following dental extraction. As the amount prescribed did not relieve the pain, he increased the amount, taking "2 boxes" in three days. On admission he showed marked lethargy, disorientation, loss of memory, and lateral nystagmus. The W. B. C. was 9,oo0, with polymorphonuclears 64 per cent and eosinophiles 2 per cent. With no medication'other than forced fluids and rest in bed, the patient was well three days later.
Case 6. The patient, a white woman of 48 years, who had been accustomed to taking daily I½ gr. of Luminal for over a year, took twelve i Y2 gr. Luminal tablets with suicidal intent.
When found several hours later she was in coma, the face was flushed and her respirations were IS per minute. The W. B. C. was i6,ooo, with polymorphonuclears 70 per cent. She responded to symptomatic treatment and five days later had completely recovered.
Case 7. A white woman of 28 years was admitted to the hospital four hours after taking ten I Y2 gr. Luminal tablets.
Examination showed marked cyanosis, and rapid, jerky, and shallow respirations, with a rate of 30 per minute. She was deeply comatose. The W. B.} C. was 8,ooo, with polymorphonuclears 79 per cent. She responded to symptomatic treatment and recovered in three days. Case 8. The patient, a woman of 48 years, had been given Veronal io gr. b.i.d. for the relief of abdominal pain. As this did not relieve her, she increased the dose, taking IIO gr. within 24 hours. She was admitted to the hospital after she had been in coma for four days. At the time of admission she could be aroused from coma, but was quite irrational. The knee jerks and ankle jerks were absent. The patient showed a febrile reaction but no leucocytosis for four days more, and then gradually improved. Two weeks after admission the tendon reflexes were normal and the patient was well.
Case 9. Because of insomnia, the patient, a boy of I9 years, took 40 grains of Veronal. He was found in a stuporous condition the following morning. When aroused he complained of dizziness and double vision. Speech was thick and he had difficulty in finding words. On admission, two days later, he was very drowsy. The pupils were sluggish, there was drooping of the eyelids, marked lateral and slight vertical nystagmus, ataxia, and the abdominal and plantar reflexes were absent. The W. B. C. was 3,600, with polymorphonuclears 79 per cent. Four days later the patient had entirely recovered.
Case io. A woman of 73 years was admitted because of mental confusion and inability to walk. The history revealed that she had been taking "large doses" of Veronal nightly for several years. Examination showed dysarthria, mental confusion, lateral nystagmus and ataxia. The blood count was normal. No medication was given. Five days after admission she was clear mentally and at the end of ten days was able to walk.
Case ii. The patient was a woman of 3 I years, who had taken i 2 Veronal tablets with suicidal intent. She was found two hours later and brought to the hospital. At this time she was in deep coma and the respirations were I2 per minute. The W. B. C. was 6,ooo, with polymorphonuclears 54 per cent and eosinophiles 2 per cent. Gastric lavage was done and the patient was given stimulants. Two days later she had recovered entirely.
These cases serve to illustrate the two types of reaction to Luminal and Veronal.
It is of interest that the cases showing a dermatitis had received, as a rule, much smaller doses than had those with symptoms of poisoning. Conversely, none of the poisoning cases showed skin reactions. The blood counts in these cases are similar to those previously reported. The most marked variations in the white blood cell counts and in the eosinophilia occurred in the dermatitis group.
The one fatal case is of importance not only because of the outcome but because it shows that the exfoliative reaction is not confined to the skin. In this case it extended to involve the bronchi, kidney pelves and ureters. This suggests that the mechanism of death in exfoliative dermatitis is bronchial obstruction, and not bronchopneumonia.
In many cases of drug rashes the causative agent is not always known, due to the fact that several drugs may have been administered. In Case i of this series the diagnosis was established by the appearance of the rash when the drug was again administered. In Case 3 the positive skin test appears to be satisfactory proof of the causative agent. It is, therefore, suggested that a skin test with the drug be used then it is suspected as the cause.
The mechanism of the reaction in the poisoning cases is relatively clear. In the dermatitis cases, the relative infrequency, DRUG REACTIONS FROM BARBITAL AND PHENOBARBITAL 35I the type of skin rash, the blood picture, and the reaction to intradermal skin tests suggest a drug idiosyncrasy, allergic in nature. SUMMARY i. Attention is called to the possible untoward reactions from Luminal and Veronal.
2. Eleven cases are reported, four with dermatitis and seven with general systemic reactions.
3. A fatal case, with autopsy findings, is reported. An explanation is offered of the mechanism of death in cases of exfoliative dermatitis.
4. Intradermal skin tests are suggested as a diagnostic method in these cases.
